148 related articles for article (PubMed ID: 35189708)
1. Expression of LHCGR in Pheochromocytomas Unveils an Endocrine Mechanism Connecting Pregnancy and Epinephrine Overproduction.
Lopez AG; Duparc C; Renouf S; Machevin E; Le Guillou V; Sabourin JC; Defortescu G; Buffet A; Gimenez-Roqueplo AP; Dubessy C; Louiset E; Lefebvre H
Hypertension; 2022 May; 79(5):1006-1016. PubMed ID: 35189708
[TBL] [Abstract][Full Text] [Related]
2. Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis.
Isobe K; Tatsuno I; Yashiro T; Nanmoku T; Takekoshi K; Kawakami Y; Nakai T
Regul Pept; 2003 Feb; 110(3):213-7. PubMed ID: 12573802
[TBL] [Abstract][Full Text] [Related]
3. Phaeochromocytoma: a catecholamine and oxidative stress disorder.
Pacak K
Endocr Regul; 2011 Apr; 45(2):65-90. PubMed ID: 21615192
[TBL] [Abstract][Full Text] [Related]
4. Maternal smoking and developmental changes in luteinizing hormone (LH) and the LH receptor in the fetal testis.
Fowler PA; Bhattacharya S; Gromoll J; Monteiro A; O'Shaughnessy PJ
J Clin Endocrinol Metab; 2009 Dec; 94(12):4688-95. PubMed ID: 19837924
[TBL] [Abstract][Full Text] [Related]
5. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages.
Sonoda N; Katabuchi H; Tashiro H; Ohba T; Nishimura R; Minegishi T; Okamura H
Placenta; 2005 Apr; 26(4):298-307. PubMed ID: 15823616
[TBL] [Abstract][Full Text] [Related]
6. Severe arterial hypertension and hyperandrogenism in a boy: a rare case of catecholamine- and β-HCG-secreting pheochromocytoma.
Chiale F; Abrigo E; Lonati L; Di Rosa G; Morra I; Peruzzi L; Einaudi S
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1193-1197. PubMed ID: 31490776
[TBL] [Abstract][Full Text] [Related]
7. Identification of Key Receptor Residues Discriminating Human Chorionic Gonadotropin (hCG)- and Luteinizing Hormone (LH)-Specific Signaling.
Lazzaretti C; Secco V; Paradiso E; Sperduti S; Rutz C; Kreuchwig A; Krause G; Simoni M; Casarini L
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375708
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of endothelin-1, endothelin-3 and endothelin receptors in human pheochromocytoma and paraganglioma.
Watanabe K; Hiraki H; Hasegawa H; Tanigawa T; Emura I; Honma K; Shibuya H; Fukuda T; Suzuki T
Pathol Int; 1997 Aug; 47(8):540-6. PubMed ID: 9293534
[TBL] [Abstract][Full Text] [Related]
9. Association of hCG and LHCGR expression patterns with clinicopathological parameters in ovarian cancer.
Zhong Y; Wang Y; Huang J; Xu X; Pan W; Gao S; Zhang Y; Su M
Pathol Res Pract; 2019 Apr; 215(4):748-754. PubMed ID: 30712886
[TBL] [Abstract][Full Text] [Related]
10. Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors.
Guillemot J; Compagnon P; Cartier D; Thouennon E; Bastard C; Lihrmann I; Pichon P; Thuillez C; Plouin PF; Bertherat J; Anouar Y; Kuhn JM; Yon L; Lefebvre H
Endocr Relat Cancer; 2009 Mar; 16(1):281-90. PubMed ID: 18948374
[TBL] [Abstract][Full Text] [Related]
11. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
12. [Pheochromocytomas and paragangliomas: implications of new insights for diagnosis and treatment].
van der Kleij-Corssmit EP; Havekes B; Vriends AH; Jansen JC; Romijn JA
Ned Tijdschr Geneeskd; 2008 Mar; 152(9):489-93. PubMed ID: 18389879
[TBL] [Abstract][Full Text] [Related]
13. Genetics of pheochromocytomas and paragangliomas.
Opocher G; Schiavi F
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
[TBL] [Abstract][Full Text] [Related]
15. Expression of mRNA coding for four catecholamine-synthesizing enzymes in human adrenal pheochromocytomas.
Isobe K; Nakai T; Yukimasa N; Nanmoku T; Takekoshi K; Nomura F
Eur J Endocrinol; 1998 Apr; 138(4):383-7. PubMed ID: 9578504
[TBL] [Abstract][Full Text] [Related]
16. Human pheochromocytomas show reduced p27Kip1 expression that is not associated with somatic gene mutations and rarely with deletions.
Pellegata NS; Quintanilla-Martinez L; Keller G; Liyanarachchi S; Höfler H; Atkinson MJ; Fend F
Virchows Arch; 2007 Jul; 451(1):37-46. PubMed ID: 17554557
[TBL] [Abstract][Full Text] [Related]
17. MANAGEMENT OF CATECHOLAMINE-SECRETING TUMORS IN PREGNANCY: A REVIEW.
Prete A; Paragliola RM; Salvatori R; Corsello SM
Endocr Pract; 2016 Mar; 22(3):357-70. PubMed ID: 26536138
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
Guo Z; Lloyd RV
Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
[TBL] [Abstract][Full Text] [Related]
19. Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.
Sadow PM; Rumilla KM; Erickson LA; Lloyd RV
Endocr Pathol; 2008; 19(2):97-103. PubMed ID: 18461287
[TBL] [Abstract][Full Text] [Related]
20. Pheochromocytomas and secreting paragangliomas.
Plouin PF; Gimenez-Roqueplo AP
Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
